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The TCR on CD4+ T cells generally recognizes fragments of protein antigens
that are processed by APCs and presented bound to syngeneic class II MHC mole-
cules (1-3). Since most T cells recognize synthetic peptides on the surface of fixed
or inactivated APCs, it is presumed that after internalization, intact proteins are
processed to a form analogous to that after partial proteolysis (4, 5). The molecular
events involved in antigen processing are not dearly understood. We have used recom-
binant mutant proteins ofstaphylococcal nuclease that differ from the native protein
by one amino acid to investigate the role of structural alterations in protein mole-
cules that affect processing and presentation ofprotein antigens. Evidence is presented
that a single amino acid change in the native protein affects the structure of the
processed peptide in such a manner that stimulatory determinants are no longer
presented to certain T cell clones, despite the fact that (a) other nuclease-specific
T cells remain responsive to the mutant protein and (b) a synthetic peptide corre-
sponding to the immunodominant region of the mutant protein is highly stimula-
tory to both groups of nuclease-specific T cells.
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Mice.
￿
B10.A, B10.A (5R), and (B10.A x B10)F, male mice were purchased from The
Jackson Laboratory, Bar Harbor, ME.
Antigens.
￿
Recombinant wild-type staphylococcal nuclease (Nase) and mutant nucleases
were prepared from an alkaline phosphatase-staphylococcal nuclease gene hybrid carried on
the pFoG405 plasmid generously provided by Dr. David Shortle (6). Proteins were isolated
from Eacherichia coli transformants and purified on CM-Sephadex, C-25 (PharmaciaFine Chem-
icals, Piscataway, NJ). Recombinant nucleases were >95% pure by SDS-PAGE and staining
with Coomassie blue. Protein concentration was determined by the method of Lowry. Nase
peptides were synthesized on a 430a automated peptide synthesizer (Applied Biosystems,
Inc., FosterCity, CA). Peptides were cleaved from the resin using anhydrous HF and purified
by reverse-phase chromatography. Peptides were >95% pure. Peptides were generously
provided by Judy Regan and Dr. Kenneth Seamon.
T Cell Clones.
￿
Nase-specific T cell clones were derived from immunization of (B6 x
A/J)F, mice (7). T cells were grown in the presence ofantigen 20 U/ml human rIL-2 (Cetus
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Corp., Emeryville, CA), and irradiated (4,000 rad) syngeneic spleen cells in RPMI 1640 con-
taining 7% FCS, 10 mM Hepes, 0.1 mM nonessential amino acids, 1 mM sodium pyruvate,
2 MM r.-glutamine, 50 AM 2-ME, and antibiotics and maintained in culture by restimula-
tion every 2 wk.
Proliferation.
￿
T cell activation was measured by incubating 104 T cells with 4 x 105 ir-
radiated spleen cells (4,000 rad) with the indicated amount of antigen. The amount of
[3H]TdR (specific activity, 1 pCi/well; ICN Radiochemicals, Irvine, CA) incorporated into
proliferating cells after a 12-h pulse was assessed at 72 h. The results are expressed as the
mean of three replicate cultures. SD was <15%. For reasons of simplicity SD values are not
detailed in the data given, All experiments were performed at least three times.
Results and Discussion
We have previously reported that in the response of (B6 x A/J)Fi mice to the
protein staphylococcal nuclease (Nase), E'-restricted T cell clones preferentially
recognize the Nase (81-100) peptide (7). Furthermore, truncation to the 15 amino
acid peptide 86-100 preserves maximal T cell stimulation (Finnegan, A., manuscript
submitted for publication). One clone, N40, recognizes Nase and the 86-100 pep-
tide in association with both M.A. (E~ E~) and B10.A (5R) (E~ Es) spleen cells used
as APC, although 102-103-fold greater antigen concentration was required to give
equal stimulation with Ea Es APCs (Fig. 1 A). When substitutions in the 86-100
peptide were analyzed for T cell stimulatory capacity, all ofthe Ek-restricted clones
recognized the 86-100 peptide substituted at residue 89 (leu to phe) presented by
B10.A stimulator cells. However, the potency of the 89-substituted peptide was 10-
fold less than the native 86-100 peptide. In contrast, using M.A. (5R) stimulator
cells, clone N40 recognized the 89 substituted peptide 10-fold more efficiently than
the native 86-100 peptide (Fig. 1 B). A change in the class II molecule Ek Ek k versus
Ea Es could significantly alter the conformation of the peptide bound to the class
II molecule or the orientation ofthe peptide in the binding site of the class II mole-
cule. These effects could contribute to an increase in the affinity of N40's TCR for
the ligand, determined by the 89-substituted peptide and the Ea Es molecule.
The response of T cells to small peptides may not predict completely the responses
to larger proteins containing these peptide sequences. Antigen processing and pre-
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FIGURE 1.
￿
(A) The Tcell clone N40 recognizes Nase more efficiently on B10.A APC (Ek Es)
than on B10.A (5R) (Ek Es) stimulator cells. 104 cloneN40 T cells were incubated with titrated
amounts of Nase in the presence of 4 x 105 BIO.A (A) and B10.A (5R) (A) stimulatorcells. (B)
The Tcell cloneN40 recognizes the 89 substituted (leu to phe) peptide more efficiently on BIO.A
(5R) (Ek .Es)APC than on B10.A (Ek, Ek k3)APC. 104 clone N40 Tcell were incubated with titrated
amounts of peptide in the presence of 4 x 105 B10.A, 86-100 peptide ("), 89 substituted pep-
tide (/) and BIO.A (5R), 86-100 peptide (O), 89 substituted peptide (C).sentation may be influenced by changes in amino acid sequences that do not have
equivalent effects on Tcell responses to small synthetic peptides. To test this possi-
bility T cell responses to a series of recombinant staphylococcal nuclease mutant
proteins with single amino acid changes were examined. These mutant nucleases
were constructed by gap misrepair mutagenesis ofthestaphylococcal nuclease gene
and isolated fromE. colitransformants (6). The mutant protein with an amino acid
change atresidue 89(leu to phe)was analyzed sincethiscorrespondstothe substitu-
tion in the synthetic 86-100 peptide that did not abrogate T cell recognition. Al-
though clone N40 was able to recognize the 89 substituted peptide and the native
nuclease (Fig. 1), the response to the corresponding 89 mutant protein was >10' less
potent in the presenceofB10.A APC (Fig. 2A). To determineifaprocessed peptide
can be generated from the 89 mutant protein and presented by the E«1: 1,0 molecule,
another Ek-restricted, Nase-specific T cell clone was used. Clone G53 recognizes
an epitopeon the 86-100 peptide different from that recognized by clone N40 (data
not shown). In contrast to N40, clone G53 efficiently recognized both the native
nuclease and the 89 mutant protein when presented by B10.A stimulator cells (Fig.
2 B). Thus, theB10.AAPCs present aprocessed peptideofthe 89mutant that binds
to the Ea Es class II molecule and is efficiently presented to the clone G53. How-
ever, the structure ofthe endogenously produced peptide derived from the 89 mu-
tant protein must be different from that derived from the native nuclease protein
since binding ofthe processed peptide to the Ea Ek 6molecule efficientlypresents the
epitope recognized by clone G53 but-not the epitope recognized by clone N40.
Next, the ability ofB10.A(5R) APC to process and present the 89-mutantprotein
to clone N40 wastested sinceclone N40recognizes thesynthetic peptide substituted
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FIGURE 2.
￿
B10.A APC can present the 89 mutant nuclease to clone G53 but not clone N40,
whereas B10.A (5R) and (B10 x B10.A)FI APC can present the T cell epitope recognized by
clone N40. Clone N40 stimulated with B10.A (A), done G53 stimulated with B10.A (B), clone
N40 stimulated with B10.A (5R) (C), and (B10 x B10.A)FI (D), in the presence ofwild-type Nase
(O) and in the presence of 89 mutant nuclease (").2174
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at 89 more efficiently with B10.A (5R) APC than with B10.A APC. Interestingly,
N40 effectively recognized the 89 mutant protein when processed and presented by
B10.A (5R) Ea Eo or (B10 x B10.A)Fi stimulator cells (Fig. 2, C and D). Further-
more, the 89 mutant proteinwas recognized moreefficientlythan thenative nuclease
protein on B10.A (5R) APC.
A single substitution in the native nuclease protein dramatically affects the fine
specificity ofT cell recognition. The 89 substitution is located within the region of
the molecule recognized by Nase-specific T cell clones but appearsto have an effect
distal to this region. This is determined by the fact that clone N40 responds to the
89 substituted peptide but not to the 89 mutant protein suggesting that a peptide
that is probably larger than 15 amino acids is necessary for the 89 substitution to
have its influence. This findingisdistinct andcomplements recent evidencedemon-
strating that structural differences in homologous proteins that are located outside
ofthe T celldeterminantcan affect cloned Tcell responses. Flanking sequencesout-
sideofthe minimal peptide required forT cell recognition have been identified that
have both positive and negative effects on T cell recognition (8-11). Thus, naturally
processed peptides may contain structures that interfere with presentation of the
determinants recognized inthe synthetic peptide (12, 13). Differences innative and
mutant processedpeptides could be created (a) by changing the location ofproteo-
lytic cleavage sitesinthe mutant protein, (b)bythe 89 substitution itself influencing
the conformation ofthe processedpeptide, or(c) by acombination ofthese mecha-
nisms. Class I- and class II-restrictedT cellshave been identified thatwhenprimed
to a particular peptide are unable to respond to the native protein from which the
peptidewasderived, implying thatantigenprocessing influenceswhichpeptides are
available for T cell recognition (12, 14, 15).
Thechange inpotencyofthe mutant 89 protein couldbe dueto achange in affinity
ofthe processed peptide for the class II molecule such that only T cell clones with
receptors ofhighaffinity would be triggered by this peptide-classII complex. Clone
N40is infact ahigher affinity clone thantheotherNase-specificTcellsbythecriterion
that it requires a lower concentration of antigen to give maximal stimulation (data
not shown). It is more likely that the conformation ofthe peptide when bound to
the E.Esmolecule results in the failure to express the determinants recognized by
clone N40. These determinants could either be specific T cell contact sites on the
peptide or sites formed from the interaction of peptide with the class II molecule.
There is a MHC difference in recognition of the processed 89 mutant protein
by clone N40. This is unlikely due to genetically determined differences in antigen
processing since the background genes of B10.A and B10.A (5R) are identical and
wouldbe expectedto share non-MHC genes involved in processing. Thus, the MHC
difference probablyinvolvestheinteractionofthe processedpeptidewith allele-specific
residues in the class II molecules. A similar result was observed with MHC class
I-restricted T cell clones (13). The B10.A and B10.A (5R) E a chains are identical
and the E S chains differ at only four amino acids (16, 17). The change in amino
acid 89 from leu to phe, which increases the potency ofthe 86-100 peptide and the
mutant protein forpresentation byB10.A (5R) APC, may forexamplehelpto orient
the processed peptides binding to the E« Es molecule in a configuration that
efficientlyexposesTcell epitopes forrecognition. Alternatively, thephysical associa-
tion of the peptides with the Ea E0 molecule may create a complex that interactsFINNEGAN AND AMBURGEY
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with the TCR ofN40 with high affinity. At present there is no consensus as to the
conformation that peptides adopt when bound to class II or that class II molecules
adopt when bound by peptides (18, 19).
The evidence presented here implies that antigen processing and/or presentation
of single amino acid variants has the potential to influence the fine specificity of
T cell recognition. The demonstration that the antigen processing system handles
mutant proteins differently from synthetic peptides may be relevant to the design
of synthetic peptide vaccines that may not induce an immunological crossreactive
response to native proteins.
Summary
Nase-specific T cell recognize the86-100 peptide in association with B10.A APC.
Clone N40 recognizes the 86-100 peptide in association with B10.A (Ea E#) and
B10.A (5R) (E« Eb) APCs. We demonstrate here that a single amino acid substitu-
tion in the staphylococcal nuclease protein alters the structure ofthe processed pep-
tide such that the T cell epitope recognized by clone N40 was only available for rec-
ognition in conjunction with BRA (5R) but not the B10.A APCs. Other Nase-specific
T cells recognize the mutant nuclease, and a synthetic peptide corresponding to the
immunodominant region of the mutant protein was stimulatory for all the Nase-
specific T cells. These results suggest that the mutation either affects the processing
of the protein into antigenic peptides or affects the conformation of the processed
fragment differently from that of the peptide.
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